Polatom
Polatom is a Polish government-owned radioisotope centre within NCBJ that manufactures and distributes radiopharmaceuticals, radiochemical reagents, sealed radiation sources, and radioactivity standards using the MARIA research reactor, supplying nuclear medicine departments, research institutions, and industrial customers globally.
- Company typePrivate
- Founded1974
- HeadquartersOtwock, Poland
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Polatom does
Polatom operates as the Radioisotope Centre of Poland's National Centre for Nuclear Research (NCBJ), a government-owned state research entity headquartered in Otwock-Świerk, Poland. Founded as a division of NCBJ with the commissioning of the MARIA research reactor in 1974, the company manufactures and distributes isotope preparations for medicine, science, industry, and environmental protection. Its product portfolio spans radiopharmaceuticals (including the 99Mo/99mTc generator, SPECT imaging kits, 131I preparations, and palliative bone metastases treatments), radiochemical reagents produced from MARIA reactor-irradiated targets, sealed radiation sources (75Se, 192Ir, 60Co) for industrial radiography, and standard radioactive solutions for metrology. The company also runs a preclinical research laboratory and offers accredited calibration services.
The underlying technology platform is built around the MARIA research reactor (50 years operational as of 2024) supplemented by cyclotron-based radionuclide production, GMP-compliant radiopharmaceutical manufacturing with end-to-end quality control, and the only laboratory in Poland capable of absolute alpha, beta, and gamma radionuclide activity measurements using primary methods — a role formally recognized through its custodianship of the National Standard of Radioactive Activity since 1999. Production capacity covers 66 radiopharmaceuticals, 41 radiochemical reagents, 90 radioactivity standards products, and 3 sealed source products, totaling more than 500 catalogued items.
Polatom generates revenue through direct B2B sales with customized quotations across multiple streams: radiopharmaceutical manufacturing and distribution, radiochemical reagents, sealed radiation sources, accredited calibration/metrology services, pharmaceutical wholesale distribution of imported products (from partners such as Eckert & Ziegler, Curium, Rotop Pharmaka, DLD Diagnostika), and specialized air logistics for time-sensitive radioactive materials. Customer segments are diversified across nuclear medicine departments and hospitals (primarily diagnostic imaging and oncology therapy), research institutions and universities, industrial radiography companies, and calibration laboratories, with over 95% of Ir-192 source production exported globally and particularly strong penetration in Far East markets.
Polatom firmographics
Firmographics- Name
- Polatom
- Legal name
- Narodowe Centrum Badań Jądrowych Ośrodek Radioizotopów – POLATOM
- Website
- https://polatom.pl
- Company type
- Private
- Founded year
- 1974
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Polatom is a Polish government-owned radioisotope centre within NCBJ that manufactures and distributes radiopharmaceuticals, radiochemical reagents, sealed radiation sources, and radioactivity standards using the MARIA research reactor, supplying nuclear medicine departments, research institutions, and industrial customers globally.
- Ownership category
- akta.pro rank
Polatom industry classification
Industry- Product category
- Radiopharmaceutical Manufacturing
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414), Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Radioisotope Production (Reactor/Cyclotron/Gamma) (HLAIAGAD)
- akta.pro secondary industries
- Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.) (EUAKAIAA), Radiopharmacy Compounding & Dispensing (Hospital/Commercial) (HLAIAGAE), Therapeutic Radiopharmaceuticals (Radioligand/Targeted Radionuclide Therapy) (HLAIAGAB), Radiopharmaceutical Manufacturing & CDMO (Synthesis, GMP, Packaging, QA/QC) (EUAKAIAC), Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine) (HLAIAGAJ)
Keywords
Where Polatom is headquartered
LocationHeadquarters
- HQ city
- Otwock
- HQ country
- Poland
- HQ region
- Europe
Offices1 record
Markets served
Polatom business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Radiopharmaceutical Products: Manufacturing and distribution of radiopharmaceuticals including generators, SPECT kits, radioiodine preparations, and therapeutic precursors for nuclear medicine applications.
- Radiochemical Reagents: Production and sale of radiochemical reagents produced from targets irradiated in the MARIA research reactor, serving scientific and industrial customers.
- Sealed Radiation Sources: Manufacturing of sealed sources (75Se, 192Ir, 60Co) for industrial radiography, non-destructive testing, and industrial process control applications.
- Radioactivity Standards and Calibration Services: Accredited calibration laboratory services including activity measurements, reference source calibration, and metrology services for nuclear medicine facilities.
- Imported Radiopharmaceuticals and Equipment: Import and distribution of third-party radiopharmaceuticals, diagnostic kits, closed sources, measurement and shielding equipment for nuclear medicine departments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | B2B direct sales with customized quotations |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels3 records
Polatom product offering
Product offeringCore offering
Polatom manufactures and distributes radioisotope preparations, including radiopharmaceuticals (such as 99Mo/99mTc generators, SPECT kits, and 131I preparations), radiochemical reagents, sealed radiation sources (75Se, 192Ir, 60Co), and standard radioactive solutions used in nuclear medicine diagnostics, therapy, scientific research, industrial radiography, and environmental protection. The company also offers accredited calibration/metrology services and preclinical research services.
Product overview
Polatom (Narodowe Centrum Badań Jądrowych Ośrodek Radioizotopów – POLATOM) is a Polish manufacturer and distributor of isotope preparations for medicine, science, industry, and environmental protection. The product portfolio centers on radiopharmaceuticals including the 99Mo/99mTc generator, SPECT imaging kits, and 131I preparations; supported by radiochemical reagents produced from the MARIA research reactor; sealed radiation sources (75Se, 192Ir, 60Co) for industrial radiography; and standard radioactive solutions for calibration. Research and development products include GMP-grade DOTATATE, PSMA-11, PSMA-T4, and ascorbic acid for radiopharmaceutical development. The company also offers preclinical research services, logistics services for radioactive materials transport, and radioactivity standards calibration through its accredited laboratory.
Differentiator
Problem solved
Functional benefit
Products and services
- Radiopharmaceuticals (Radiofarmaceutyki)
- Radiochemical Reagents (Odczynniki radiochemiczne)
- Sealed Radiation Sources (Źródła zamknięte)
- Standard Solutions and Sources (Roztwory i Źródła wzorcowe)
- Laboratory of Preclinical Studies
- Logistic Services
- DOTATATE
- PSMA-11
- PSMA-T4 (PSMA-HYNIC)
- Ascorbic Acid
Quantifiable outcome
- Only laboratory in Poland performing absolute alpha, beta, and gamma radionuclide measurements
- +2 more outcomes
Companies that use Polatom
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Polatom technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Polatom partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- National Centre for Nuclear Research (NCBJ)coreParent organization and consortium leader. POLATOM operates as the Radioisotope Centre within NCBJ. The CERAD project is coordinated by NCBJ with consortium partners including Warsaw University, Institute of Nuclear Chemistry and Technology, Warsaw Medical University, Jagiellonian University Collegium Medicum, and Medical University in Białystok.
- Warsaw University (Uniwersytet Warszawski)minorCERAD consortium partner contributing to radiopharmaceutical research infrastructure development.
- Institute of Nuclear Chemistry and Technology (IChTJ)minorCERAD consortium partner in Warsaw specializing in nuclear chemistry research.
- Warsaw Medical University (WUM)minorCERAD consortium partner providing clinical research perspective for radiopharmaceutical development.
- Jagiellonian University Collegium MedicumminorCERAD consortium partner contributing clinical research capabilities.
- Medical University in BiałystokminorCERAD consortium partner supporting radiopharmaceutical research.
- Eckert & Ziegler GmbHminorSupplier of radiopharmaceutical products imported and distributed through POLATOM's pharmaceutical wholesale operation.
- Curium/CIS bio Int.minorInternational radiopharmaceutical supplier whose products complement POLATOM's product portfolio.
- Rotop Pharmaka AGminorRadiopharmaceutical product supplier distributed through POLATOM.
- DLD Diagnostika GmbHminorDiagnostic product supplier for POLATOM's import and distribution operations.
- IZOTOPminorIsotope product supplier included in POLATOM's supplier network.
- LOT Polish AirlinesminorPrimary airline partner for air freight of radioactive materials from Warsaw Chopin Airport, enabling 24/7 logistics operations for time-sensitive radiopharmaceutical shipments.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Polatom competitors and assessment
Company assessmentDirect peers
- Rotop Pharmaka: German specialist radiopharmaceutical CDMO and product supplier (Tc-99m generators, SPECT kits, therapeutic radiopharmaceuticals). Existing supplier partner of Polatom; comparable GMP manufacturing scope and nuclear medicine customer base across Europe.
- Nordion: Canadian-based supplier of medical isotopes including Mo-99 from the Bruce reactor and gamma-sterilization services. Overlapping with Polatom's Mo-99/Tc-99m generator franchise and sealed source / Co-60 industrial sterilization exposure.
- Curium: One of the world's largest nuclear medicine-focused manufacturers, producing SPECT imaging agents (Tc-99m generators, kits) and therapeutic radiopharmaceuticals. Closely comparable to Polatom across product portfolio, customer base (nuclear medicine departments), and GMP manufacturing model.
- NTP Radioisotopes (SOC Ltd): South African state-owned producer of Mo-99 and other medical/industrial radioisotopes from the SAFARI-1 research reactor. Near-identical business model to Polatom as a state-owned entity commercializing reactor-based isotope production for global export.
- IRE (Institut National des Radioéléments): Belgian producer of medical radioisotopes and radiopharmaceuticals (Mo-99, I-131, Lu-177 precursors) for global nuclear medicine supply. Directly comparable in production capabilities, European customer base, and GMP-manufactured product mix.
- Lantheus Holdings: US-listed diagnostic radiopharmaceutical specialist (DEFINITY, Xenon-133, Technecium generators) heavily focused on SPECT imaging agents and growing PSMA-PET franchise. Closely comparable to Polatom's SPECT-kit product line and direct nuclear medicine customer overlap.
- Eckert & Ziegler: German manufacturer of radioisotopes, radiopharmaceuticals and radiation therapy sources, including Lu-177 and Y-90 therapeutic products. Already a supplier partner of Polatom's wholesale operations; directly overlapping in therapeutic and industrial isotope manufacturing.
Emerging players
- Telix Pharmaceuticals: Commercial-stage theranostics company commercializing Illuccix (PSMA-PET) and advancing Lu-177 PSMA and alpha-emitter therapies. A direct emerging competitor to Polatom's PSMA-11 / DOTATATE R&D pipeline in prostate cancer and neuroendocrine tumor imaging and therapy.
- IBA (Ion Beam Applications) — Radiopharma Solutions: Cyclotron vendor and emerging radiopharma CDMO/developer (cyclone-produced Tc-99m, PET tracers). Adjacent/emerging technology overlap with Polatom's cyclotron-based production and represents both a potential alternative production-route supplier and indirect competitor.
Broad incumbents
- GE HealthCare: Global healthcare technology incumbent combining diagnostic imaging equipment (SPECT/PET scanners) with a radiopharmaceuticals portfolio (Omnipaque contrast, PET tracer network). Overlaps with Polatom on the nuclear medicine demand side and competes broadly in imaging-agent supply.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Polatom social profiles
Digital presencePolatom compliance and trust
Trust signalCompliance6 records
Polatom financial estimates
Financial estimateRevenue estimate
Valuation estimate
Polatom leadership team
Management profileNumber of profiles
Profiles3 records
Polatom funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Polatom M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Polatom
What does Polatom do?
Polatom manufactures and distributes radioisotope preparations, including radiopharmaceuticals (such as 99Mo/99mTc generators, SPECT kits, and 131I preparations), radiochemical reagents, sealed radiation sources (75Se, 192Ir, 60Co), and standard radioactive solutions used in nuclear medicine diagnostics, therapy, scientific research, industrial radiography, and environmental protection. The company also offers accredited calibration/metrology services and preclinical research services.
Is Polatom a public or private company?
Polatom is a private company. It is classified as state government owned and is currently operating.
When was Polatom founded?
Polatom was founded in 1974. It employs 251 to 500 people.
Where is Polatom based?
Polatom is headquartered in Otwock, Poland, in the Europe region.
How does Polatom make money?
Five revenue lines are on record. Radiopharmaceutical Products are the primary driver. The others are radiochemical Reagents, sealed Radiation Sources, radioactivity Standards and Calibration Services and imported Radiopharmaceuticals and Equipment.
Who are Polatom's main competitors?
Direct peers on record are Rotop Pharmaka, Nordion, Curium, NTP Radioisotopes (SOC Ltd), IRE (Institut National des Radioéléments), Lantheus Holdings and Eckert & Ziegler. Emerging players are Telix Pharmaceuticals and IBA (Ion Beam Applications) — Radiopharma Solutions. GE HealthCare is listed as a broad incumbent.
Does Polatom have an API?
No public API is recorded for Polatom.
What industry is Polatom in?
Polatom's product category is Radiopharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAGAD, Radioisotope Production (Reactor/Cyclotron/Gamma), with a secondary code of EUAKAIAA, Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.). Its NAICS code is 325413 and its SIC code is 2835.